|Home | About | Journals | Submit | Contact Us | Français|
The relationship between luminal stenosis measured by coronary CT angiography (CCTA) and severity of stress-induced ischemia seen on single photon emission computed tomographic myocardial perfusion imaging (SPECT-MPI) is not clearly defined. We sought to evaluate the relationship between stenosis severity assessed by CCTA and ischemia on SPECT-MPI.
ECG-gated CCTA (64 slice dual source CT) and SPECT-MPI were performed within 6 months in 292 patients (ages 26-91, 73% male) with no prior history of coronary artery disease. Maximal coronary luminal narrowing, graded as 0, ≥25%, 50%, 70%, or 90% visual diameter reduction, was consensually assessed by two expert readers. Perfusion defect on SPECT-MPI was assessed by computer-assisted visual interpretation by an expert reader using the standard 17 segment, 5 point-scoring model (stress perfusion defect of ≥5% = abnormal). By SPECT-MPI, abnormal perfusion was seen in 46/292 patients. With increasing stenosis severity, positive predictive value (PPV) increased (42%, 51%, and 74%, P = .01) and negative predictive value was relatively unchanged (97%, 95%, and 91%) in detecting perfusion abnormalities on SPECT-MPI. In a receiver operator curve analysis, stenosis of 50% and 70% were equally effective in differentiating between the presence and absence of ischemia. In a multivariate analysis that included stenosis severity, multivessel disease, plaque composition, and presence of serial stenoses in a coronary artery, the strongest predictors of ischemia were stenosis of 50-89%, odds ratio (OR) 7.31, P = .001, stenosis ≥90%, OR 34.05, P = .0001, and serial stenosis ≥50% OR of 3.55, P = .006.
The PPV of CCTA for ischemia by SPECT-MPI rises as stenosis severity increases. Luminal stenosis ≥90% on CCTA strongly predicts ischemia, while <50% stenosis strongly predicts the absence of ischemia. Serial stenosis of ≥50% in a vessel may offer incremental value in addition to stenosis severity in predicting ischemia.
Coronary CT angiography (CCTA) provides excellent anatomic assessment of the extent and severity of coronary artery disease (CAD), with high diagnostic accuracy for detection of significant stenosis in patients who present with symptoms suggestive of ischemia.1-4 With its high negative predictive value, CCTA has become useful for exclusion of CAD in patients with chest pain syndromes. However, the clinical management of a patient with an abnormal CCTA is not well defined. Single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) is an accepted standard for detection and quantification of significant myocardial ischemia and has been shown to be a strong prognostic indicator of the risk for adverse cardiac events.5,6 The increasing use of CCTA for diagnosis of CAD has led to several studies comparing stenosis severity on CCTA to ischemia on SPECT-MPI7-11 and PET.12 However, these reports have been limited by modest-sized, heterogeneous populations that often included patients known to have CAD. Furthermore, previous studies have not addressed the relationship between CCTA-based assessment of plaque characteristics and ischemia by SPECT-MPI. In this study, we compared CCTA-based assessment of stenosis severity to SPECT-MPI in a large cohort of consecutive patients with no previous history of CAD. Our objectives were to determine whether there is a degree of luminal stenosis on CCTA above which myocardial ischemia on SPECT-MPI is highly likely, to determine the degree of stenosis severity below which abnormal SPECT-MPI is so unlikely that further diagnostic testing would not be required, and to explore whether the distribution of significant stenoses in the vessel can improve prediction of myocardial ischemia.
We studied 294 consecutive patients without known CAD—defined by history of myocardial infarction, coronary revascularization, or presence of angiographically documented coronary stenoses of ≥50% luminal diameter by invasive coronary angiography—participating in the Cedars-Sinai Cardiac Imaging Database Registry and undergoing both CCTA and SPECT-MPI for suspected ischemic heart disease at Cedars-Sinai Medical Center within 6 months. These patients did not experience change in symptoms or coronary revascularization between the examinations. Two patients with excessive motion artifact on CCTA were excluded. Pre-test likelihood of CAD before the first test performed was determined according to the Diamond and Forrester method using <15%, >85%, and 15-85% for low, high, and intermediate pre-test likelihood, respectively.13,14 The study protocol was approved by the Cedars-Sinai Institutional Review Board, and all patients included in the study provided informed consent for the use of their clinical and imaging data.
CCTA was performed on a SOMATOM Definition dual-source computed tomography scanner (Siemens Medical Systems, Forchheim, Germany) which employs a flying focus along the z-axis with two different focal spots, acquiring 64 overlapping .6-mm image slices with a temporal resolution of 83 ms.15 The CCTA protocol has been previously described in detail.16 Unless contraindicated, a sublingual spray of .4 mg nitroglycerin (Sciele Pharma, Alpharetta, Georgia) was administered and 80 mL of intravenous contrast (Omnipaque or Visipaque, GE Healthcare, Princeton, New Jersey) was injected into the antecubital vein at 5 mL · s−1, followed by 80 mL of saline at 5 mL · s−1. ECG-gated scanning from 1 cm below the tracheal bifurcation to the level of the diaphragm was performed in a single breath-hold. Scanning parameters included heart rate-dependent pitch (.2 to .45), 330 ms gantry rotation time, 100 or 120 kVp tube voltage, and 600 mAs tube current. Dose modulation protocols were implemented according to our previously described methods.17 The effective radiation dose in the patients, using the various acquisition protocols, was 11.3 ± 6.4 mSv.
Retrospectively gated reconstruction of raw CCTA data was performed at 40% (when available), 65%, 70%, 75%, and 80% of the R-R interval using the following parameters: .6-mm slice thickness (.75 mm if BMI >35 kg · m−2), .3-mm slice increment, 250-mm field-of view, 512 × 512 matrix, and B26f “medium smooth” kernel or a B46f “sharp” kernel in patients with dense coronary calcium (calcium score >100).
Reconstructed data were transferred to a Siemens workstation (Leonardo; Siemens Medical solutions) or a Hewlett-Packard workstation (Palo Alto, California) running the Vitrea 2 clinical software (Vital Images, Minnetonka, Minnesota). CCTA examinations were read for this research by two experienced CCTA readers (B. T. and R. N.) blinded to patient clinical status, SPECT-MPI, and clinically reported CCTA findings. Observers visually assessed each coronary segment using standard axial images, oblique multiplanar reformations, and oblique maximum intensity projections.18 Twenty-five coronary segments including the left main (LM) were analyzed and for the purpose of per-vessel analysis, the maximal stenosis from each of the three major coronary arteries were used.19 With respect to branching vessels, the diagonal and ramus intermediate branch were combined with the left anterior descending artery (LAD), the obtuse marginal (OM) branch combined with the left circumflex (LCX) and the posterolateral and posterior descending artery combined with the right coronary artery (RCA) or the LCX depending on whether they originated from the RCA or LCX. Maximal diameter stenosis severity was visually graded by consensus between the two observers on a scale of 0 to 6 (0 = 0%, 1 = 1% to 24%, 2 = 25% to 49%, 3 = 50% to 69%, 4 = 70% to 89%, 5 = 90% to 99%, and 6 = 100%).20 We had demonstrated previously that visual stenosis assessment by this grading system and quantitative CT-based stenosis assessment were equivalent when compared to stenosis quantification by invasive angiography.20 Plaque was further characterized as calcified or non-calcified plaque as described previously.21 When plaque contained both calcified and non-calcified components with neither of them constituting >75% of the plaque volume it was described as a partially calcified or mixed plaque. Data were analyzed after excluding all patients with densely calcified plaque for per-patient analysis and after excluding all vessels with dense calcification for per-vessel analysis. A secondary analysis was performed by including all patients and vessels with dense calcification. For this analysis the artery with dense calcification obscuring the coronary lumen was considered to have a maximal luminal stenosis ≥90%. For assignment of plaque distribution within individual vessels, the ramus intermediate branch was considered an extension of the proximal LAD, the diagonal branch an extension of the mid-LAD, the OM branches an extension of the proximal circumflex and the PDA and posterolateral branches an extension of the distal RCA or distal LCX depending on coronary dominance. For quantification of coronary artery calcium, all CT images were reviewed by an expert reader, using semi-automatic commercially available software (ScImage, Los Altos, CA). Total Agatston CCS was calculated as the sum of calcified plaque scores of all coronary arteries.22
Patients were instructed to discontinue beta-blockers and calcium antagonists 48 hours and nitrates 24 hours before testing. Rest perfusion images were acquired 10 minutes after infusion of 7-9 mCi of 99mTc-sestamibi or 3-4.5 mCi of 201Tl (based on body weight). Stress testing was performed with a symptom-limited Bruce treadmill exercise protocol or vasodilator challenge, as described previously.23 At near-maximal exercise, 99mTc-sestamibi (32-40 mCi based on patient weight) was injected intravenously, after which treadmill exercise was continued at maximal workload for 1 minute and at one stage lower for two additional minutes whenever possible. 99mTc-sestamibi MPI acquisition was started 15-30 minutes after radiopharmaceutical injection. For vasodilator stress, adenosine was infused at 140 μg · kg−1 · min−1 for 5 minutes and in ambulatory patients, a low-level treadmill exercise was performed during adenosine infusion.24 At the end of the second minute, 99mTc-sestamibi (32-40 mCi) was injected and myocardial imaging was started approximately 60 minutes later.6 Twelve lead electrocardiography (ECG) was monitored continuously during stress testing. Horizontal or downsloping ST-segment depression ≥1 mm or upsloping ≥1.5 mm were considered positive for ischemia.
SPECT images were acquired with a 2-detector gamma camera (Philips Adac Forte or Vertex, Philips Medical Systems, Cleveland, Ohio or E-Cam, Siemens Medical Solutions). High-resolution collimators were used, and acquisition consisted of 64 projections over a 180° orbit, with 64 projections at 25 s/projection for supine 99mTc acquisition followed immediately by 15 s/projection for prone 99mTc acquisition.25 Rest 201Tl acquisition was performed at 35 s/projection in supine position only. At each of the 64 projection angles, the image data were recorded into 16 equal ECG-gated time bins. No attenuation or scatter correction was applied. After iterative reconstruction (12 iterations) with Butterworth prefiltering (cutoff, .66 cycle/pixel for supine 99mTc, .55 cycle/pixel for prone 99mTc; order 5), short-axis images were automatically generated.26
All SPECT MPI studies were reanalyzed quantitatively for purposes of this research study, using an objective, automatic computer analysis.27 Automatically generated myocardial contours were evaluated by a core laboratory technologist without knowledge of any clinical data, and when necessary, contours were adjusted to correspond to the myocardium (8% of cases). A qualitative assessment of image quality using a visual 5-point scale (1 = uninterpretable, 2 = poor, 3 = fair, 4 = good, and 5 = excellent) was performed. The quantitative perfusion variable employed was total perfusion deficit (TPD), which is a validated, computer-derived analog of the percent myocardium abnormal by visual analysis, representing both extent and severity of perfusion defect.28 TPD was calculated as the percentage of the total surface area of the left ventricle below the predefined uniform average deviation threshold using QPS software.27 TPD was measured at stress and rest, and patients with a stress TPD of ≥5% were considered abnormal and were considered to represent myocardial ischemia in these patients with no known CAD.28,29 A computer-derived maximum severity score was also quantified using QPS software and was expressed on a scale of 0-4 (0 = normal and 4 = absence of tracer uptake) for each patient and for each coronary territory.27 Defects in the anterior and septal wall were allocated to the left anterior descending coronary artery (LAD); in the lateral wall, the left circumflex coronary artery (LCX); in the inferior wall, right coronary artery (RCA). When the assignment of a perfusion defect to a vascular territory was not clear (watershed regions), we used automated fusion software described previously and assigned the vessel according to the large vessel supplying the region in question.30
Continuous variables were expressed with median and range. Categorical variables were expressed as percentages. The severity of luminal stenosis, presence perfusion defects by SPECT-MPI, and frequency of perfusion defects were considered categorical variables. The Wilcoxon sum test, and a Kruskall Wallis test were used to compare continuous variables and Pearson Chi-square tests were used to compare ordinal variables. Sensitivity, specificity, and other diagnostic test measures were used to compare the different cut points of degree of stenosis to predict ischemia. Receiver operating characteristic (ROC) curves were constructed to assess the discriminatory value of various CCTA stenosis cutoffs in detecting the presence and absence of inducible ischemia by SPECT-MPI. The measured areas under the ROC curves were compared as described by Hanley and McNeil.31 CCTA-based imaging features of coronary artery stenosis including luminal stenosis severity, plaque composition, number of coronary arteries with stenosis ≥50%, and the presence of serial stenoses ≥50% were included in a stepwise fashion in a multivariable logistic regression analysis and adjusted for baseline clinical risk factors to determine the strongest significant predictors of ischemia. A P-value of <.05 was considered significant. Data were analyzed using STATA software version 9 (www.stata.com).
Of the 292 patients, 192 were men (66%, see Table 1). The median age was 62 years (range, 26-91), and the median pretest likelihood of CAD (before the first test) was 58% (range, 2-96%). Seventy percent (n = 203) of patients had chest discomfort or shortness of breath before the first test that persisted at the time of the second test. The remaining 30% (n = 89) had either equivocal or abnormal results on the first test (n = 43), or discordant results (e.g., abnormal stress ECG, normal SPECT-MPI) (n = 27). In seven patients, the results of the first test resulted in a higher post-test likelihood prompting a second test and in 12 patients the reason for the second test was not clear. The duration between studies ranged from 0 to 178 days with a median of 4 days. Overall, in 75% of patients SPECT-MPI and CCTA were performed within 2 weeks.
Exercise stress testing was used in 201 (68%) of patients, of whom 97% achieved >85% of maximal predicated heart rate. Adenosine stress was employed in the remaining 91 (32%) patients. Stress perfusion abnormalities were seen in 46 patients (15.4%). In patients with abnormal perfusion, stress TPD ranged from 5% to 48% with a median defect of 14% and ischemic TPD (Stress TPD-Rest TPD) ranged from 4% to 16% with a median defect of 6%. The proportion of patients with stress perfusion abnormalities was similar between pharmacologic and exercise stress. Perfusion defects were localized to the LAD in 29 patients, LCX in 13 patients and RCA in 17 patients. There were 12 patients with stress-induced perfusion defects in more than 1 vascular territory.
CCTA study quality was excellent or good in 283 studies (97%) and fair in 6 studies. Calcium scores ranged from 0 to 4305 with a median score of 35. Nine patients had dense calcification in one or more coronary arteries were excluded from the primary analysis. A secondary analysis was performed by considering these patients to have a maximal stenosis of ≥90%. Ninety-four patients (32%) had no detectable coronary artery plaque, 104 (35%) had plaque causing a maximal luminal stenosis of >0% and <50% of the vessel diameter, 58 (20%) had a maximal stenosis of ≥50% and <90%, and 27 (9%) had a maximal stenosis of ≥90%. In 27 patients, two or more coronary arteries exhibited luminal stenosis of ≥70%. Maximal stenosis was found in a proximal segment in 54% of patients, in a mid segment in 16%, in a distal segment in 6%, and in multiple locations in the same vessel (serial stenoses) in 24%. In patients with any detectable plaque, calcified plaque caused the maximal stenosis in 42%, partially calcified plaque in 41%, and non-calcified plaque in 17%.
On a per-vessel basis, 473 arteries were found to have no stenosis, 271 had a maximal stenosis of >0% and <50%, 80 had a maximal stenosis of ≥50% and <90%, and 38 had a maximal stenosis of ≥90%. There were 13 coronary arteries with dense calcium in which luminal stenosis could not be reliably assessed by both expert readers.
With increasing grades of stenosis severity from 0% to 100%, there was an increase in the proportion of individuals with abnormal myocardial perfusion by SPECT-MPI, P = .001 (Figure 1). Only a small proportion of patients with <50% stenosis on CCTA had stress perfusion defects, including three of 94 patients (3%) without coronary artery plaque (stress TPD 5-6%) (Figure 1) and three of 59 patients (5%) with atherosclerotic plaque and a maximal luminal narrowing of 1-24% (stress TPD 5-8%). A progressive increase in the frequency of ischemia was observed in the >50% stenosis categories. Among patients with a luminal stenosis severity of 50-70%, 17% were found to have perfusion abnormalities by SPECT-MP increasing to 42% and 74% when maximal stenosis was 70-89% and 90-100%, respectively (Figure 1).
Among all patients with luminal stenosis of 0-24%, 25-49%, and 50-69%, mean TPD was low, .05 ± .31, .12 ± .48, and .72 ± 1.14, respectively, P = ns (Figure 2). There was a significant increase in the mean stress TPD to 3.2 ± 3.5 and 12.9 ± 12.84 when stenosis severity increased to 50-89% and 90-100% (Figure 2). Similarly, when the mean severity of stress perfusion defects alone was considered, there was no significant difference in severity scores in patients with maximal luminal narrowing of 0-24%, 25-49%, and 50-69% (.19 ± .31, .001 ± .0, and .29 ± .48, respectively, P = ns (Figure 3). When maximal luminal stenosis increased to the 70-89% and 90-100% categories, there was a proportional increase in the severity of stress perfusion abnormality to .72 ± .14 and 2.58 ± 1.34, respectively (P < .001 and P < .0001, respectively) (Figure 3). While the stenosis category 50-69% was usually not associated with ischemia, 17% of these patients manifested stress-induced ischemia on SPECT-MPI as noted above.
The positive predictive value (PPV) of CCTA for abnormal stress perfusion increased in proportion to the severity of luminal stenosis, 42%, 51%, and 74% for <50% stenosis, 50-89% stenosis, and ≥90% stenosis, respectively, P = .01 (Table 2) with only a minor change in NPV (97%, 95%, and 91%). Similar results were obtained in a per-vessel analysis; increasing degrees of luminal stenosis resulted in a similar increase in PPV, 38%, 51%, and 68% for <50% stenosis, 50-89% stenosis, and ≥90% stenosis, respectively, P = .001. Whereas, NPV remained unchanged (98%, 98%, and 97%) (Table 2). When patients with vessels containing dense calcification were included in a secondary analysis, there was still a progressive increase in the PPV of CCTA for stress perfusion defect with increasing severity of luminal stenosis on both a per-patient and per-vessel basis and the NPV remained relatively unchanged (Table 2).
On a per-patient basis, there was a strong association between the coronary artery with the maximal luminal stenosis and the region of myocardium affected by ischemia: 40 (87%) patients exhibited stress-induced ischemia in territories perfused by arteries with luminal stenosis of maximal severity that ranged from 50% to 100%. An example of a patient with a 70-89% stenosis in the proximal RCA with a stress perfusion defect in the corresponding vascular territory is shown in Figure 4. There were 12 patients with stress-induced perfusion defects in more than one vascular territory. In three of these patients, the ischemic territory was in a watershed region that could have been ascribed to the LCX or the RCA. In these patients the assignment of the perfusion territory was based on fusion imaging and coronary dominance.
In six patients, luminal stenosis was absent or minimal (0-24%) in the vessels that corresponded to the ischemic territories. The quality of SPECT-MPI images in five of these patients was suboptimal from motion or breast attenuation artifact and they were unable to undergo prone imaging. A sixth patient was found to have severe left ventricular hypertrophy by CCTA without significant coronary artery stenosis.
On a per-patient basis, the areas under the curve (AUC) were significantly higher for both the 50% stenosis and 70% stenosis cut-offs, compared to the 90% stenosis cut-off (.825 and .816, respectively, vs .725, P = .01, Figure 5). There was no significant difference between the AUC seen with 50% and 70% stenosis cut-offs.
Univariable analysis was used to identify variables that were associated with ischemia among patients with coronary artery stenosis. In addition to traditional risk factors such as increasing age, male gender, hypertension, hyperlipidemia, and diabetes, the severity of luminal stenosis, presence of multiple vessels containing ≥50% stenoses and serial ≥50% stenoses in one coronary artery were strongly associated with ischemia.
Among patients with stenosis of ≥50%, prevalence of ischemia was significantly different between patients, based on whether plaque ≥50% was located in the proximal, mid, distal, or multiple segments of the vessel (Table 3A). The odds of ischemia increased 4.2 fold (95% confidence interval (95% CI) 1.7-10.1, P = .002) when serial ≥50% stenoses were identified in a single vessel (Table 3A). When patients with >90% stenosis were excluded, a strong association between serial stenoses ≥50% and the prevalence of ischemia still remained (Table 3B). The odds of ischemia increased 4.4-fold (95% CI 1.68-11.7, P = .004) when serial ≥50% stenoses were identified in a single vessel in patients with a maximal stenosis of 50-90%.
When the association of ischemia was compared between patients with single vessel stenosis vs multivessel stenoses, patients with ≥50% stenosis in two or more vessels were more likely to have ischemia when compared to individuals with stenosis in a single vessel (Table 4). When the relationship between plaque composition and ischemia was evaluated, ischemia was more commonly associated with non-calcified or partially calcified plaque when compared to calcified plaque. In a univariable model, on a per patient basis, the odds of ischemia was greater when the maximal stenosis was caused by non-calcified plaque (OR of 4.89, 95% CI 1.05-22.73, P = .04); however, partially calcified and calcified plaque were not strongly associated with ischemia (Table 4).
For identification of CCTA predictors of ischemia, a multivariable model was designed to include degrees of stenosis severity (<50%, 50-89%, and ≥90%), plaque composition (calcified, non-calcified, and partially calcified plaque), stenosis ≥50% in multiple vessels and location of stenosis ≥50% (proximal, mid, distal, or serial stenoses). When this model was applied to all 292 patients, the most significant predictor of ischemia was stenosis severity with an OR of 7.31, 95% CI of 2.35-22.70, P = .001, for 50-89% stenosis, and OR of 34.05, 95% CI of 10.60-109.34, P = .0001, for stenosis ≥90%. Serial stenosis of ≥50% remained significant as a predictor of ischemia with an OR of 3.55, 95% CI of 1.43-8.84, P = .006 (Table 5). Although multivessel disease was associated with ischemia in the univariable model (Table 4), this association was not preserved when confounding variables such as stenosis severity, and plaque location were added to the model (Table 5).
In this head-to-head comparison of stenosis severity assessment by CCTA and myocardial perfusion by SPECT-MPI, we observe the following key findings. One, there is a direct relationship between luminal stenosis severity measured by CCTA and the prevalence of ischemia measured by SPECT-MPI. Two, at the extremes of luminal stenosis severity, <50% (NPV of 98%) or ≥90% (PPV of 74%), CCTA capably predicts the absence or presence of ischemia. On the other hand, there is wide variability in the prevalence of ischemia among patients with a luminal stenosis severity of 50-90%. Three, the presence of multiple plaques causing a stenosis ≥50% in the same vessel is strongly associated with ischemia on SPECT-MPI. To our knowledge, this is the first study showing that CCTA-based detection of serial lesions of ≥50% stenosis are more likely than single lesions to be associated with ischemia. Additionally, this is the first direct comparison of CCTA and automatic computer-based quantitation of SPECT-MPI in patients without a history of CAD to be reported from a single center.
Our results are similar to observations by other investigators who showed that 31-50% of all individuals with a maximal stenosis of more than 50% had ischemia with a prevalence of ischemia ranging from 16% to 20% in the subgroup of individuals with a maximal stenosis of 50-75%.7-12 When patients with coronary arteries containing dense calcium were excluded from analysis, we found an improvement in PPV and specificity of diagnosing ischemia. To more accurately reflect clinical decision making, we employed an intention-to-diagnose approach, and therefore included a secondary analysis in which segments with dense calcium were considered to have maximal stenosis. This approach has been used by other investigators,3,7-10 whose studies uniformly found that, when nonevaluable segments were scored as having maximal stenosis, sensitivity increased at the expense of specificity.
Compared to a maximal stenosis threshold of 90%, a 50% or a 70% maximal stenosis provide a significantly increased sensitivity and only a small decrease in specificity resulting in a greater area under the ROC curve. Based on the ROC analysis, the 50% and 70% stenosis cutoffs were similarly effective in discriminating between patients with and without ischemia on SPECT-MPI. While the 50-69% category was not statistically different from the lesser degrees of stenosis with respect to the prevalence of ischemia, this category showed a trend toward increase in the prevalence and combined extent and severity of ischemia. The lack of statistical difference in this category may be due to the small sample size. Our findings are similar to what was reported by Di Carli et al in their comparison of stenosis severity by CCTA and myocardial ischemia by PET12 and by Sato et al in their comparison of CCTA and SPECT.9 Careful examination of our SPECT-MPI results indicates that perfusion defects seen in 5 out of the 6 individuals with <50% luminal stenosis by CCTA were most likely caused by factors unrelated to coronary artery stenosis. A 50% stenosis threshold on CCTA may therefore provide a safe cutoff below which ischemia could be ruled out. Importantly, in a large sample of 114 arteries in 89 patients whose maximal stenosis was 25-50%, ischemia was not observed, implying that these patients do not need to be considered for ischemia testing. These findings are concordant with our recent observations that only 1.9% of 25-50% lesions by CCTA are associated with >70% stenosis by invasive coronary angiography.20 Our observations highlight the importance of the complementary role of myocardial perfusion imaging in individuals with luminal stenosis of intermediate severity and the need for improving CCTA-based detection of myocardial ischemia beyond that available from assessment of stenosis severity. In patients with ≥90% stenosis and without dense calcification, the high prevalence of abnormal SPECT-MPI (74%) suggests that it may be reasonable to assume such lesions are ischemia producing without needing further testing.
Previous studies have shown an association between non-calcified and partially calcified plaque with myocardial ischemia.32-35 In our analysis, there was a significant association of non-calcified plaque with ischemia in a univariable model; however, this association was not preserved when other confounding factors such as stenosis severity were considered in the multivariable model. Our analysis also revealed a strong relationship between multivessel ≥50% stenotic disease and ischemia that faded when accounting for the presence of high grade stenosis.
When we evaluated the relationship between serial stenoses and ischemia, we found that presence of multiple significant stenoses in the same vessel was strongly associated with ischemia on SPECT-MPI. The strong relationship between serial stenoses and ischemia remained even after adjustments for severity of individual luminal stenosis were made. This observation is consistent with the physiological effect of serial stenoses on resistance to coronary blood flow that has previously been described in both experimental animals and in patients with epicardial coronary artery disease.36,37 In the presence of serial stenoses, the net resistance to coronary blood flow is determined by the sum of the individual resistances and can result in greater stress-induced impairment of myocardial perfusion compared to a single stenosis with the same reduction in luminal diameter.36,37 The incremental value of detecting serial ≥50% stenosis when assessing coronary arteries by CCTA could potentially improve our ability to identify individuals likely to manifest inducible ischemia.
Our studies were a retrospective analysis of patients who had undergone SPECT-MPI and CCTA within 6 months. Although this is a fairly long duration between studies, the median duration between studies was 4 days and 75% of patients underwent both studies within 2 weeks. Moreover, patients considered for analysis did not have a change in clinical status between the studies. Our study included a significant number of patients with low pretest likelihood of CAD and this may be reflected in the lower prevalence of ischemia (16%) in our overall study population, compared to other studies in which the prevalence ranged between 40% and 50%.7-10 Our analysis does not use invasive angiography as the gold standard in comparison to CCTA-based stenosis assessment. However, stenosis severity defined anatomically has limitations in predicting functional significance since it does not account for collateral flow, vascular tone, or plaque geometry, variables that could potentially influence coronary blood flow. On the other hand, SPECT-MPI offers an accurate assessment of the hemodynamic significance of coronary artery stenosis especially in lesions that may not appear to be severe by angiography and the prognostic significance of ischemia detected by SPECT-MPI has been well established.5,6 We have therefore chosen to compare CCTA-based stenosis to a functional assessment of coronary perfusion based on SPECT-MPI. SPECT-MPI may fail to detect ischemia in patients with three-vessel or left main disease due to a balanced reduction of flow and may therefore be suboptimal as a gold standard for ischemia.38 This may be better resolved in future studies where CCTA-based stenosis assessment is compared to absolute coronary blood flow and flow reserve measurements using PET myocardial perfusion.
While non-calcified plaque tended to be highly associated with ischemia compared to calcified plaque and serial stenoses tend to be more predictive of ischemia on SPECT compared to isolated stenoses of the same severity, the modest proportion of patients with ischemia (16%) or with stenosis in the intermediate range of 50-70% (11%), limits the inclusion of other plaque characteristics such as positive remodeling, plaque volume, spotty calcification, or presence of large lipid core in a multivariable analysis. We suspect that consideration of additional CCTA-based imaging features of plaque assessment may be most useful in patients with intermediate-severity stenoses.
The presence of ischemia increases in proportion to the severity of luminal stenosis and the PPV of ischemia measured by SPECT-MPI rises as stenosis severity increases. A luminal stenosis of ≥90% by CCTA is a strong predictor of ischemia on SPECT-MPI. Individuals with luminal stenosis of <50% are so unlikely to have myocardial ischemia that such patients may generally not need ischemia testing. In the group of individuals with luminal stenosis of ≥50%, the presence of serial luminal stenoses of ≥50% may offer incremental value in identifying individuals at risk for ischemia.
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Balaji K. Tamarappoo and Ariel Gutstein contributed equally to this work.
The study was supported in part by grants from the Lincy Foundation and Diane and Gilford Glazer.
Balaji K. Tamarappoo, Email: email@example.com.
Daniel S. Berman, Email: gro.shsc@dnamreb.